Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „edoxaban“
Suchtreffer
Begriffe & Kennungen
Kaletra · 4.5 · 15 Dabigatran etexilate, Dabigatran etexilate, Clinical monitoring and/or dose Edoxaban Edoxaban: reduction of
Eintrag öffnenLixiana · 4.5 · 10 Edoxaban 60 mg once daily is recommended during concomitant use with the following P-gp inhibitors: • Quini
Eintrag öffnenLixiana · 4.5 · 11 There is very limited experience on the use of edoxaban with dual antiplatelet therapy or fibrinolytic agen
Eintrag öffnenLixiana · 4.5 · ASA Co-administration of ASA (100 mg or 325 mg) and edoxaban increased bleeding time relative to either medici
Eintrag öffnenLixiana · 4.5 · Anticoagulants Co-administration of edoxaban with other anticoagulants is contraindicated due to increased ris
Eintrag öffnenLixiana · 4.5 · Co-administration of edoxaban with the P-gp inducer rifampicin led to a decrease in mean edoxaban AUC and a sh
Eintrag öffnenLixiana · 4.5 · Digoxin Edoxaban 60 mg once daily on days 1 to 14 with coadministration of multiple daily doses of digoxin 0.2
Eintrag öffnenLixiana · 4.5 · Edoxaban 30 mg once daily must be administered during concomitant use with the following P-gp inhibitors: • Ci
Eintrag öffnenLixiana · 4.5 · Edoxaban decreased the Cmax and AUC of concomitantly administered verapamil by 14% and 16%, respectively.
Eintrag öffnenLixiana · 4.5 · Edoxaban increased the Cmax of concomitantly administered digoxin by 28%; however, the AUC was not affected. E
Eintrag öffnenLixiana · 4.5 · Edoxaban is a substrate for the efflux transporter P-gp. In pharmacokinetic (PK) studies, concomitant administ
Eintrag öffnenLixiana · 4.5 · Edoxaban is predominantly absorbed in the upper gastrointestinal (GI) tract. Thus, medicinal products or disea
Eintrag öffnenLixiana · 4.5 · Effect of edoxaban on other medicinal products
Eintrag öffnenLixiana · 4.5 · NSAIDs Co-administration of naproxen and edoxaban increased bleeding time relative to either medicinal product
Eintrag öffnenLixiana · 4.8 · 12 The most commonly reported adverse reactions associated with edoxaban treatment are epistaxis (7.7%), haema
Eintrag öffnenLixiana · 4.8 · 14 145 patients treated with edoxaban) and cardiac diseases at risk of thrombotic events (167 patients, 109 pa
Eintrag öffnenLixiana · 4.8 · Haemorrhagic anaemia Due to the pharmacological mode of action, the use of edoxaban may be associated with an
Eintrag öffnenLixiana · 4.8 · The safety of edoxaban was evaluated in two Phase 3 studies (Hokusai VTE PEDIATRICS and ENNOBLE-ATE) in paedia
Eintrag öffnenLixiana · 4.8 · The safety profile of edoxaban is based on two Phase 3 studies (21,105 patients with NVAF and 8,292 patients w
Eintrag öffnenPrezista · 4.5 · 57 Dabigatran etexilate dabigatran etexilate (150 mg): Darunavir/ritonavir: Edoxaban darunavir/ritonavir 800/1
Eintrag öffnen